The Sigma-1 Receptor as a Regulator of Dopamine Neurotransmission: A Potential Therapeutic Target for Methamphetamine Addiction

Por Sambo, Danielle O., Lebowitz, Joseph J., Khoshbouei, Habibeh
Publicado no Pharmacol Ther (2018)

Clustered Kv2.1 decreases dopamine transporter activity and internalization

Por Lebowitz, Joseph J., Pino, Jose A., Mackie, Phillip M., Lin, Min, Hurst, Cheyenne, Divita, Keeley, Collins, Anthony T., Koutzoumis, Dimitri N., Torres, Gonzalo E., Khoshbouei, Habibeh
Publicado no J Biol Chem (2019)

INVOLVEMENT OF NEUROINFLAMMATION IN THE PATHOGENESIS OF MONOCROTALINE-INDUCED PULMONARY HYPERTENSION

Por Sharma, Ravindra K., Oliveira, Aline C., Kim, Seungbum, Rigatto, Katya, Zubcevic, Jasenka, Rathinasabapathy, Anandharajan, Kumar, Ashok, Lebowitz, Joseph J., Khoshbouei, Habibeh, Lobaton, Gilberto, Aquino, Victor, Richards, Elaine M., Katovich, Michael J., Shenoy, Vinayak, Raizada, Mohan K.
Publicado no Hypertension (2018)

The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission

Por Sambo, Danielle O., Lin, Min, Owens, Anthony, Lebowitz, Joseph J., Richardson, Ben, Jagnarine, Darin A., Shetty, Madhur, Rodriquez, Meghan, Alonge, Taiwo, Ali, Mishaal, Katz, Jonathan, Yan, Long, Febo, Marcelo, Henry, L. Keith, Bruijnzeel, Adriaan W., Daws, Lynette, Khoshbouei, Habibeh
Publicado no Nat Commun (2017)